Synmosa Biopharma (Taiwan) Technical Analysis
| 4114 Stock | TWD 34.25 0.15 0.44% |
As of the 4th of December, Synmosa Biopharma has the Risk Adjusted Performance of (0.17), variance of 0.5687, and Coefficient Of Variation of (458.73). Synmosa Biopharma technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Synmosa Biopharma standard deviation, information ratio, maximum drawdown, as well as the relationship between the variance and treynor ratio to decide if Synmosa Biopharma is priced more or less accurately, providing market reflects its prevalent price of 34.25 per share.
Synmosa Biopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Synmosa, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SynmosaSynmosa |
Synmosa Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Synmosa Biopharma Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Synmosa Biopharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Synmosa Biopharma Trend Analysis
Use this graph to draw trend lines for Synmosa Biopharma. You can use it to identify possible trend reversals for Synmosa Biopharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Synmosa Biopharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Synmosa Biopharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Synmosa Biopharma applied against its price change over selected period. The best fit line has a slop of 0.06 , which may suggest that Synmosa Biopharma market price will keep on failing further. It has 122 observation points and a regression sum of squares at 130.69, which is the sum of squared deviations for the predicted Synmosa Biopharma price change compared to its average price change.About Synmosa Biopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Synmosa Biopharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Synmosa Biopharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Synmosa Biopharma price pattern first instead of the macroeconomic environment surrounding Synmosa Biopharma. By analyzing Synmosa Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Synmosa Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Synmosa Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Synmosa Biopharma December 4, 2024 Technical Indicators
Most technical analysis of Synmosa help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Synmosa from various momentum indicators to cycle indicators. When you analyze Synmosa charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.17) | |||
| Market Risk Adjusted Performance | (1.70) | |||
| Mean Deviation | 0.4693 | |||
| Coefficient Of Variation | (458.73) | |||
| Standard Deviation | 0.7541 | |||
| Variance | 0.5687 | |||
| Information Ratio | (0.37) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | (1.71) | |||
| Maximum Drawdown | 5.33 | |||
| Value At Risk | (1.15) | |||
| Potential Upside | 0.7968 | |||
| Skewness | (1.89) | |||
| Kurtosis | 8.69 |
Additional Tools for Synmosa Stock Analysis
When running Synmosa Biopharma's price analysis, check to measure Synmosa Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synmosa Biopharma is operating at the current time. Most of Synmosa Biopharma's value examination focuses on studying past and present price action to predict the probability of Synmosa Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synmosa Biopharma's price. Additionally, you may evaluate how the addition of Synmosa Biopharma to your portfolios can decrease your overall portfolio volatility.